Dennis Podlesak, Director at AVANIR PHARMACEUTICALS (AVNR), bought 1,000 shares at $9.90 ($10K) on 2006-05-31, disclosed to the SEC on 2006-06-02.
Open-market purchase of $10k AVNR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.90 | 800 | $8K | 80.0% |
| 2 | $9.91 | 200 | $2K | 20.0% |
| Total | $9.90 avg | 1,000 | $10K | 100% |
| Filing → |
| SNDX | BUY | 2021-04-22 | $394K | — | Filing → |